Miguel G. Toscano

Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.

In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.

Safer vectors for gene therapy of primary immunodeficiencies.

Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.

Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.

Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family.

Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines.